{"nct_id":"NCT00394836","title":"HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab","status":"COMPLETED","status_verified_date":"2013-11","start_date":"2007-05","start_date_type":null,"primary_completion_date":"2009-04","primary_completion_date_type":"ACTUAL","completion_date":"2013-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}